Cancer Research UK Cambridge Institute
| Established | 2007 |
|---|---|
| Type | Research institute |
| Focus | Medical research |
| Location |
|
Director | Professor Gregory Hannon |
Employees | 430 |
| Website | www |
Formerly called | Cancer Research UK Cambridge Research Institute |
The Cancer Research UK Cambridge Institute is a department of the University of Cambridge and one of the largest cancer research facilities in Europe[1]. Opened in 2007 by Queen Elizabeth II[2][3], it is home to 22 research groups and over 430 members of research and support staff[4]. The Institute was a joint partnership between the University of Cambridge and Cancer Research UK and, since 2013, it has sat within the School of Clinical Medicine.[5][6]
The Institute is located in the Li Ka Shing Centre on the Cambridge Biomedical Campus, close to Addenbrooke's Hospital.[7]
Research Strategy[edit]
The Cancer Research UK Cambridge Institute was established to solve problems associated with the prevention, diagnosis and treatment of cancer.[8] It particularly focuses on the practical application of basic research into patient care. The Institute undertakes research in four key areas[9]
1. Basic research into the cellular and molecular biology of cancer.
2. Research in molecular imaging, genomics, bioinformatics and computational biology.
3. Research focused on specific cancers, which form a link between laboratory and clinic.
4. Clinical investigations including experimental medicine clinical trials and, in the longer term, population-based studies in screening and prevention.
Leadership and Governance[edit]
The Institute is led by the director, Professor Gregory Hannon, and the Scientific Advisory Board. The Scientific Advisory Board is chaired by Peter Jones of the Van Andel Research Institute, and consists of Ed Harlow, Douglas Fearon, Johanna Joyce, Scott W. Lowe, Charles J Sherr and Zena Werb.[10]
Funding[edit]
Construction of the £50 million Li Ka Shing Centre, where the Institute is housed, was funded by the University of Cambridge, Hutchison Whampoa Ltd, Cancer Research UK and The Atlantic Philanthropies along with a range of other donors[11]. Cancer Research UK purchased approximately £15 million of equipment for the Institute.[12]
The total annual funding for the Institute in 2018 was £45 million, the half of which comes as core funding from Cancer Research UK. Approximately 37% comes from research grants from various funders. The infrastructure of the Institute is funded by Higher Education Funding Council for England generated income of £2.9 m.[13]
Directors[edit]
Professor Sir Bruce Ponder[edit]
Professor Sir Bruce Ponder was the inaugural director of the Institute with Professor Fiona Watt as deputy director.[14] During his time as director, Ponder encouraged collaboration between the clinic at Addenbrooke's Hospital and basic research, with genetic diagnoses being a key theme of the Institute.[15]
Professor Simon Tavaré[edit]
Professor Simon Tavaré became director in February 2013. As director, Tavaré ordered the redevelopment of the third floor of the Li Ka Shing Centre to expand the computational biology and bioinformatics research at the Cancer Research UK Cambridge Institute.[16]
Professor Gregory Hannon[edit]
In February 2018, Professor Gregory Hannon became the third director of the Institute.[17][18]
Groups Leaders[19][edit]
- Shankar Balasubramanian
- Sarah Bohndiek
- James Brenton
- Kevin Brindle
- Carlos Caldas
- Jason Carroll
- Maike de la Roche
- Douglas Fearon
- Fanni Gergely
- Richard Gilbertson
- Tim Halim
- Gregory Hannon
- Duncan Jodrell
- John Marioni
- Florian Markowetz
- Martin Miller
- Masashi Narita
- Duncan Odom
- Bruce Ponder
- Nitzan Rosenfeld
- Simon Tavaré
- Doug Winton
Notable former Group Leaders include Professor Fiona Watt[20] and Professor David Tuveson[21]
Core Facilities[edit]
The Institute has 12 core facilities which provide services and equipment at the Institute. Each facility has a team of staff to provide support, advice and training for all the Institute’s researchers and students[22].
- Bioinformatics
- Compliance and biobanking
- Flow cytometry
- Genomics
- Histopathology and in situ hybridisation
- Light microscopy
- Pharmacokinetics and bioanalytics
- Pre-clinical genome editing
- Pre-clinical imaging
- Proteomics
- Research instrumentation and cell services
- Scientific computing
References[edit]
- ↑ "Our institutes". Cancer Research UK. 2014-04-04. Retrieved 2018-12-11.
- ↑ "Queen opens centre". Times Higher Education (THE). 2007-02-09. Retrieved 2018-12-11.
- ↑ "Royal opening for Cambridge Research Institute". University of Cambridge. 2007-02-01. Retrieved 2018-12-11.
- ↑ "Life at the Institute". Cancer Research UK Cambridge Institute. Retrieved 2018-12-11.
- ↑ "Departments, Institutes & Units". School of Clinical Medicine. Retrieved 2018-12-11.
- ↑ "2013 Annual Report" (PDF).
- ↑ "Campus Occupiers". Cambridge Biomedical Campus. Retrieved 2018-12-11.
- ↑ "Our institutes". Cancer Research UK. 2014-04-04. Retrieved 2018-12-11.
- ↑ "The Institute". Cancer Research UK Cambridge Institute. Retrieved 2018-12-11.
- ↑ "Scientific Advisory Board". Cancer Research UK Cambridge Institute. Retrieved 2018-12-11.
- ↑ "Hutchison Whampoa Limited - Media Center > Press Releases". www.hutchison-whampoa.com. Retrieved 2018-12-11.
- ↑ "Royal opening for new £50m Cancer Research UK Cambridge Research Institute". Cancer Research UK. 2013-12-05. Retrieved 2018-12-11.
- ↑ "Funding". Cancer Research UK Cambridge Institute. Retrieved 2018-12-11.
- ↑ "World-class scientists to lead Cambridge research centre". Cancer Research UK. 2013-12-05. Retrieved 2018-12-11.
- ↑ Curtis, Polly (2007-04-03). "Interview: Bruce Ponder". The Guardian. ISSN 0261-3077. Retrieved 2018-12-11.
- ↑ "Annual Report 2013" (PDF).
- ↑ "Internationally-renowned scientist Professor Greg Hannon announced as next director of the Cancer Research UK Cambridge Institute". Cambridge Independent. 2017-11-16. Retrieved 2018-12-11.
- ↑ "Professor Greg Hannon to become director of the Cancer Research UK Cambridge Institute". Cancer Research UK. 2017-11-16. Retrieved 2018-12-11.
- ↑ "Research Groups".
- ↑ "Meet the Researcher: Fiona Watt | Eurostemcell". www.eurostemcell.org. Retrieved 2018-12-11.
- ↑ KaiserApr. 2, Jocelyn; 2015; Am, 8:00 (2015-04-02). "Cold Spring Harbor Laboratory, hospital join forces to develop cancer drugs". Science | AAAS. Retrieved 2018-12-11.
- ↑ "Core Facilities". Cancer Research UK Cambridge Institute. Retrieved 2018-12-11.
This article "Cancer Research UK Cambridge Institute" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Cancer Research UK Cambridge Institute. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
